Calendar

pharmadog

Week of Jan 19, 2026

Jan 20, 2026approval222d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Jan 20, 2026approval222d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗

Jan 20, 2026approval222d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗

Jan 20, 2026approval222d agoSITAGLIPTIN PHOSPHATE — FDA approvalSITAGLIPTIN PHOSPHATE

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →SITAGLIPTIN PHOSPHATE →fda approvals ↗

Jan 20, 2026approval222d agoSACUBITRIL AND VALSARTAN (SACUBITRIL) — FDA approvalSACUBITRIL AND VALSARTAN

Sponsor: SOMERSET THERAPS LLC. Form: TABLET. Route: ORAL

full page →SACUBITRIL AND VALSARTAN →fda approvals ↗

Jan 20, 2026approval222d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

Sponsor: APPCO. Form: CAPSULE. Route: ORAL

full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗

Jan 20, 2026grant222d agoVERSITI BLOOD HEALTH, INC. — Cytokine regulation of recirculating and tissue-resident memory CD8+ T cells ...

AI grant. $40,833. PI: Nicholas N Jarjour

full page →nih reporter ↗

Jan 20, 2026grant222d agoKEYSTONE SYMPOSIA — iPSCs: Progress, Opportunities, and Challenges

TR grant. $18,100. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Jan 20, 2026grant222d agoUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR — Role of interferon gamma in injury accelerated cystic kidney disease

DK grant. $41,998. PI: Morgan E. Smith

full page →nih reporter ↗

Jan 20, 2026grant222d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Mapping the Epigenomic and Spatial Transcriptomic Landscape in Parkinson's Di...

NS grant. $670,266. PI: Jaroslav Bendl

full page →nih reporter ↗

Jan 21, 2026approval221d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

full page →EVRYSDI →fda approvals ↗

Jan 21, 2026approval221d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

full page →EVRYSDI →fda approvals ↗

Jan 21, 2026approval221d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

full page →EVRYSDI →fda approvals ↗

Jan 21, 2026approval221d agoTYENNE (TOCILIZUMAB-AAZG) — FDA approvalTYENNE

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INTRAVENOUS

full page →TYENNE →fda approvals ↗

Jan 21, 2026approval221d agoVERQUVO (VERICIGUAT) — FDA approvalMerck & Co., Inc.

Sponsor: MSD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 21, 2026approval221d agoLACOSAMIDE — FDA approvalGlenmark Pharmaceuticals Ltd

Sponsor: GLENMARK PHARMS. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 21, 2026approval221d agoFENOFIBRATE — FDA approvalFENOFIBRATE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →FENOFIBRATE →fda approvals ↗

Jan 21, 2026approval221d agoCYCLOSPORINE — FDA approvalTWi Pharmaceuticals Inc

Sponsor: TWI PHARMS. Form: EMULSION. Route: OPHTHALMIC

full page →fda approvals ↗

Jan 21, 2026approval221d agoBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approvalBISOPROLOL FUMARATE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →BISOPROLOL FUMARATE →fda approvals ↗

Jan 21, 2026approval221d agoAVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalAVTOZMA

Sponsor: CELLTRION INC. Form: INJECTABLE. Route: IV (INFUSION)

full page →AVTOZMA →fda approvals ↗

Jan 21, 2026approval221d agoMICAFUNGIN SODIUM — FDA approvalSandoz Inc

Sponsor: HISUN PHARM HANGZHOU. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 21, 2026approval221d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

Sponsor: ASCENT PHARMS INC. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗

Jan 21, 2026grant221d agoKEYSTONE SYMPOSIA — Cardiometabolism in Health and Disease

HL grant. $18,100. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Jan 22, 2026approval220d agoATORVASTATIN CALCIUM — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoKETOROLAC TROMETHAMINE — FDA approvalKetorolac Tromethamine Apotex

Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Ketorolac Tromethamine Apotex →fda approvals ↗

Jan 22, 2026approval220d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: CADILA PHARMS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Jan 22, 2026approval220d agoOXAPROZIN — FDA approvalSolubiomix LLC

Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoTEMOZOLOMIDE — FDA approvalAreva Pharmaceuticals Inc

Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoTEMOZOLOMIDE — FDA approvalAreva Pharmaceuticals Inc

Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoACYCLOVIR — FDA approvalACYCLOVIR

Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

full page →ACYCLOVIR →fda approvals ↗

Jan 22, 2026approval220d agoAMLODIPINE BESYLATE — FDA approvalChina Resources Saike Pharmaceutical Co Ltd

Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

full page →METHADONE HYDROCHLORIDE →fda approvals ↗

Jan 22, 2026approval220d agoOSELTAMIVIR PHOSPHATE — FDA approvalF. Hoffmann-La Roche Ltd

Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approvalzilucoplan

Sponsor: UCB INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →zilucoplan →fda approvals ↗

Jan 22, 2026approval220d agoROPINIROLE HYDROCHLORIDE — FDA approvalElite Laboratories Inc

Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoROPINIROLE HYDROCHLORIDE — FDA approvalElite Laboratories Inc

Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 22, 2026approval220d agoESTRADIOL — FDA approvalestradiol ER

Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

full page →estradiol ER →fda approvals ↗

Jan 23, 2026approval219d agoSPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL

full page →fda approvals ↗

Jan 23, 2026approval219d agoEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalEPYSQLI

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION

full page →EPYSQLI →fda approvals ↗

Jan 23, 2026approval219d agoCALDOLOR (IBUPROFEN) — FDA approvalCUMBERLAND PHARMACEUTICALS INC

Sponsor: CUMBERLAND PHARMS. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 23, 2026approval219d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: OMNIVIUM PHARMS. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 23, 2026approval219d agoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

Sponsor: LUPIN. Form: TABLET. Route: ORAL

full page →naloxone hydrochloride →fda approvals ↗

Jan 23, 2026approval219d agoNALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

Sponsor: LUPIN. Form: TABLET. Route: ORAL

full page →naloxone hydrochloride →fda approvals ↗

Jan 23, 2026approval219d agoAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalinsulin human

Sponsor: MANNKIND. Form: POWDER. Route: INHALATION

full page →insulin human →fda approvals ↗

Jan 23, 2026approval219d agoJOURNAVX (SUZETRIGINE) — FDA approvalsuzetrigine

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →suzetrigine →fda approvals ↗

Jan 23, 2026grant219d agoEMORY UNIVERSITY — Contribution of cell-specific activity to functional MRIEmory University

NS grant. $577,611. PI: Shella D Keilholz

full page →nih reporter ↗

Jan 23, 2026grant219d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Understanding kidney failure in individuals with DiGeorge syndrome

DK grant. $859,998. PI: ROSEMARY V SAMPOGNA

full page →nih reporter ↗

Jan 24, 2026approval218d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 24, 2026approval218d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 24, 2026approval218d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

← prev

page 414 of 475

Week of Jan 19, 2026